AUTHOR=Haenfler Jill M. , Skariah Geena , Rodriguez Caitlin M. , Monteiro da Rocha Andre , Parent Jack M. , Smith Gary D. , Todd Peter K. 

TITLE=Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells

JOURNAL=Frontiers in Molecular Neuroscience

VOLUME=11

YEAR=2018

URL=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2018.00282

DOI=10.3389/fnmol.2018.00282

ISSN=1662-5099

ABSTRACT=<p>Fragile X Syndrome (FXS) is the most common inherited cause of intellectual disability and autism. It results from expansion of a CGG nucleotide repeat in the 5′ untranslated region (UTR) of <italic>FMR1</italic>. Large expansions elicit repeat and promoter hyper-methylation, heterochromatin formation, <italic>FMR1</italic> transcriptional silencing and loss of the Fragile X protein, FMRP. Efforts aimed at correcting the sequelae resultant from FMRP loss have thus far proven insufficient, perhaps because of FMRP’s pleiotropic functions. As the repeats do not disrupt the FMRP coding sequence, reactivation of endogenous <italic>FMR1</italic> gene expression could correct the proximal event in FXS pathogenesis. Here we utilize the Clustered Regularly Interspaced Palindromic Repeats/deficient CRISPR associated protein 9 (CRISPR/dCas9) system to selectively re-activate transcription from the silenced <italic>FMR1</italic> locus. Fusion of the transcriptional activator VP192 to dCas9 robustly enhances <italic>FMR1</italic> transcription and increases FMRP levels when targeted directly to the CGG repeat in human cells. Using a previously uncharacterized FXS human embryonic stem cell (hESC) line which acquires transcriptional silencing with serial passaging, we achieved locus-specific transcriptional re-activation of <italic>FMR1</italic> messenger RNA (mRNA) expression despite promoter and repeat methylation. However, these changes at the transcript level were not coupled with a significant elevation in FMRP protein expression in FXS cells. These studies demonstrate that directing a transcriptional activator to CGG repeats is sufficient to selectively reactivate <italic>FMR1</italic> mRNA expression in Fragile X patient stem cells.</p>